Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on the nanotechnology-driven delivery of small RNA mimics and inhibitors.

Translating today's discoveries in childhood cancer research into tomorrow's treatments.
Greehey Children’s Cancer Research Institute is only one of two institutes in the United States dedicated solely to pediatric cancer research. Its 20 laboratories focus their strengths in cancer genomics, DNA repair, RNA biology, and drug development on finding new and less toxic treatments for childhood cancers.
Top stories
News
Events
-
Greehey CCRI Seminar Series, Fall ’23: Peter W Lewis, PhD, Univ of Wisconsin
Presentation “The Role of Aberrant Heterochromatin in Pediatric Cancers” -
Greehey CCRI Seminar Series, Fall ’23: Ludmil B. Alexandrov, PhD, Moores Cancer Center, UCSD
Presentation: “Anthology of Unusual Patterns of Somatic Mutations in Cancer Genomes”